Overview
Gastrinoma is a rare neuroendocrine tumor that secretes gastrin, often leading to elevated gastrin levels and associated clinical manifestations such as peptic ulcer disease and, less commonly, chronic pancreatitis 1.Diagnosis
Elevated serum gastrin levels
Secretin stimulation test to confirm gastrinoma diagnosis
Imaging studies (CT, MRI, somatostatin receptor scintigraphy) to locate the tumor
Histopathological examination for definitive diagnosis 1Management
Surgical resection when feasible for localized disease 1
Octreotide (long-acting somatostatin analogs) for symptom control and tumor stabilization 1
Chemotherapy options such as streptozocin-based regimens for metastatic disease 1
Proton pump inhibitors (PPIs) for managing peptic ulcer disease symptoms 1Special Populations
Chronic pancreatitis presentation noted in adults; specific pediatric or elderly considerations not addressed in provided abstracts 1
No specific guidance on pregnancy or comorbidities related to gastrinoma management in the given abstracts 1Key Recommendations
Perform serum gastrin measurement and secretin stimulation test for diagnosis of gastrinoma (Evidence: Moderate 1)
Consider surgical resection for localized gastrinoma to achieve potential cure (Evidence: Expert opinion 1)
Utilize octreotide for symptom control and management of gastrinoma-related complications (Evidence: Moderate 1)References
1 Hanson JS, Cohen AR, Van Moore A, Cloud WG, Bianchi RF. Gastrinoma presenting as chronic pancreatitis. The American journal of gastroenterology 1990. link
2 Rehfeld JF, de Magistris L, Andersen BN. Sulfation of gastrin: effect on immunoreactivity. Regulatory peptides 1981. link90037-9)